| Topics | Speakers | Time | Venue |
|---|---|---|---|
| SUPERFICIAL VENOUS DISEASE I | 14.15-15.09 | Session 21 | |
| Human lymphatic glycocalyx identification |
|
14.16 | |
| The modern phlebology: from aesthetic to advanced disease. How to do it? |
|
14.22 | |
| Why the CHIVA procedure is not performed by most surgeons, despite the high scientific evidence of cost-efficacy |
|
14.28 | |
| Lesson learned from a multicenter study on endothermal ablation |
|
14.34 | |
| Saphenous vein ablation with cyanoacrylate glue: the Italian registry |
|
14.40 | |
| One fit most technique: laser can treat all refluxes and recurrencies |
|
14.46 | |
| Ablation of perforating veins: when and how? |
|
14.52 | |
| Round table/Discussion | 14.58-15.09 | ||
| SUPERFICIAL VENOUS DISEASE II | 15.10-16.04 | Session 22 | |
| Venous thromboembolic risk assessment for endovenous and foam interventions |
|
15.11 | |
| Sclerotherapy with “superfoam”: preliminary results |
|
15.17 | |
| Long term results of MOCA for saphenous vein incompetency |
|
15.23 | |
| Ballon Catheter Sclerotherapy in empty vein |
|
15.29 | |
| MOCA and crossectomy in saphenous vein insufficiency |
|
15.35 | |
| High intensity focused ultrasound (HIFU) for the treatment of truncal reflux: a potentially disruptive technology |
|
15.41 | |
| Do we need compression after superficial ablation? |
|
15.47 | |
| Round table/Discussion | 15.53-16.04 | ||
| DEEP VEIN THROMBOSIS | 16.05-16.49 | Session 23 | |
| Antithrombotic therapy after venous stenting: do we need RCTs? |
|
16.06 | |
| New devices for acute deep vein thrombosis |
|
16.12 | |
| When conservative treatment is not the best choice for Acute DVT treatment |
|
16.18 | |
| Mechanical thrombectomy may reduce intraprocedural complications |
|
16.24 | |
| Endovascular treatment of Deep Vein Thrombosis: the new intelligent clot removal concept |
|
16.30 | |
| Risk factors and classification of reintervention following deep venous stenting for acute iliofemoral deep vein thrombosis |
|
16.36 | |
| Round table/Discussion | 16.42-16.49 | ||
| KEYNOTE LECTURE IX | 16.50-16.59 | ||
| COMPRESSIVE DISEASE AND PELVIC CONGESTION SYNDROME | 17.00-17.54 | Session 24 | |
| How to assess illusory May-Thurner syndrome by ultrasound |
|
17.01 | |
| Endovascular treatment of central venous obstructive disease |
|
17.07 | |
| IVUS guidance for diagnosis and stenting of MTS |
|
17.13 | |
| Incidence, outcome, and management of venous stent migration |
|
17.19 | |
| Venous obstruction in PCS needs to be treated first |
|
17.25 | |
| Pelvic vein embolization as first choice in PCS with obstruction |
|
17.31 | |
| Pelvic Congestion Syndrome: the Italian consensus |
|
17.37 | |
| Round table/Discussion | 17.43-17.54 | ||
| POST-THROMBOTIC SYNDROME | 17.55-18.54 | Session 25 | |
| Misconceptions regarding elastic compression for prevention of post-thrombotic changes |
|
17.56 | |
| Deep valve reconstruction after outflow recanalization |
|
18.02 | |
| How to improve inflow (Access PTS) |
|
18.08 | |
| Neointima formation following venous stenting: clinical and experimental results |
|
18.14 | |
| Complex IVC reconstruction with different stent configuration |
|
18.20 | |
| Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein |
|
18.26 | |
| Current evidence on deep venous recanalization following recent trials |
|
18.32 | |
| Performance of open and closed cell laser cut nitinol stents for the treatment of chronic iliofemoral venous outflow obstruction |
|
18.38 | |
| Round table/Discussion | 18.44-18.54 |